BMC Biotechnology Q2 Unclaimed
BioMed Central Ltd.
United Kingdom
BMC Biotechnology is a journal indexed in SJR in Biotechnology with an H index of 88. It is an CC BY + CC0 Journal with a Single blind Peer Review review system, and It has a price of 2090 €. The scope of the journal is focused on biotechnology. It has an SJR impact factor of 0,654 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,654.
BMC Biotechnology focuses its scope in these topics and keywords: dna, rna, sedimentsautomated, serial, sitespecific, specimensdesign, technologya, tidal, tissue, treatmentsequential, ...
Type: Journal
Type of Copyright: CC BY + CC0
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -
Categories:
Biotechnology (Q2)
Price
2090 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,654
SJR Impact factor88
H Index38
Total Docs (Last Year)233
Total Docs (3 years)1462
Total Refs830
Total Cites (3 years)233
Citable Docs (3 years)3.54
Cites/Doc (2 years)38.47
Ref/DocOther journals with similar parameters
IEEE/ACM Transactions on Computational Biology and Bioinformatics Q2
Human gene therapy methods Q2
Journal of Applied Microbiology Q2
Journal of Microbiology Q2
Protein Engineering, Design and Selection Q2
Compare this journals
Comments